Harry Alcorn, Jr.
Overview
Harry Alcorn, Jr. received an average of $611K in total compensation, including $289K in salary, at DiaMedica Therapeutics from 2019 to 2021.
Related executives
We found five more executives who work or worked at DiaMedica Therapeutics.
Rick Pauls
DiaMedica Therapeutics
Chief Executive Officer
Scott Kellen
DiaMedica Therapeutics
Chief Financial Officer
Kirsten Gruis
DiaMedica Therapeutics
Chief Medical Officer
Julie Daves
DiaMedica Therapeutics
SVP, Clinical Development Operations
Todd Verdoorn
DiaMedica Therapeutics